Real-World Evidence Circles

11/18/2025

Despite cutting-edge algorithms, many AI models in healthcare falter in real-world application — not because of complexity, but due to poor data foundations. Incomplete, biased, or unverified data creates fragile systems that can mislead clinicians and endanger patients.

𝐓𝐡𝐞 𝐤𝐞𝐲 𝐭𝐨 𝐭𝐫𝐮𝐬𝐭𝐰𝐨𝐫𝐭𝐡𝐲 𝐀𝐈 𝐥𝐢𝐞𝐬 𝐢𝐧 𝐠𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞:

✔️Transparent data lineage
✔️Continuous validation
✔️Verifiable provenance

Innovative approaches like Circle Datasets prioritize integrity at the source, reducing downstream risks and costs. True resilience in medical AI emerges when governance is embedded into the architecture — transforming data from a liability into a reliable asset.

The path to smarter, safer healthcare starts with accountable data. Are we ready to treat data as a regulated, auditable instrument?

Effective healthcare AI requires robust data governance, provenance, and validation. Building trust and resilience is essential for safe, accurate medical decision-making.

11/14/2025

𝐑𝐞𝐠𝐞𝐧𝐌𝐞𝐝, 𝐈𝐧𝐜. 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐓𝐞𝐜𝐡𝐧𝐢𝐜𝐚𝐥 𝐏𝐚𝐫𝐭𝐧𝐞𝐫𝐬𝐡𝐢𝐩 𝐖𝐢𝐭𝐡 𝐈𝐏𝐑𝐃 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬

RegenMed is pleased to announce a strategic partnership with IPRD Solutions, a leading global provider of enterprise-level healthcare data solutions. This partnership will further accelerate the development of our patented technical platform to optimize Circle Datasets for AI healthcare models, federated data capture, and the tokenization of consented personal health records. (RegenMed’s White Papers on each of these three foundational topics are available here: https://hubs.li/Q03Tl2FF0.)

IPRD brings to the partnership deep healthcare IT architecting and coding sophistication. It has worked closely with Google, the Gates Foundation, Pew Charitable Trusts, the World Health Organization and major U.S. hospital systems. IPRD’s senior management has deep roots in, and maintains close relationships with, SRI International, IBM, and other major institutions at the forefront of modern healthcare data architecture.

RegenMed looks forward to reporting on significant technical milestones further enabling Circles to revolutionize the efficient generation and accessibility of clinically-impactful, statistically significant and fully verifiable/consented healthcare datasets.

11/13/2025

In healthcare, trust is the new currency for success. Discover how verifiable data provenance and transparency are transforming clinician confidence, regulatory compliance, and investment in AI. Building credibility isn’t about more technology — it's about ensuring trust through proven provenance. Read more to learn why verification is the key to unlocking AI’s full potential in healthcare: https://hubs.li/Q03SZdch0

11/12/2025

𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐢𝐬 𝐇𝐞𝐫𝐞: 𝐏𝐞𝐩𝐭𝐢𝐝𝐞𝐬 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐭𝐡𝐞 𝐂𝐡𝐚𝐫𝐠𝐞!

Did you know that over 11% of new pharmaceutical approvals by the FDA from 2016–2024 were synthetic peptides? In 2023 alone, peptides made up 16.3% of novel therapeutics, showcasing their rapidly growing role in innovative healthcare solutions.

CPRS is at the forefront of this revolution — bringing together clinicians, researchers, and industry leaders to accelerate peptide science. From regenerative medicine to autoimmune therapies, peptides are transforming personalized treatment options and patient outcomes.

𝐖𝐡𝐲 𝐉𝐨𝐢𝐧 𝐂𝐏𝐑𝐒?

✅Access cutting-edge research and white papers
✅Influence clinical guidelines
✅Network with pioneers in peptide science
✅Participate in exclusive workshops and webinars

📅 Don't miss the upcoming conference in Salt Lake City, November 12-16, where experts like Dr. Pagdin will explore how peptides can revolutionize patient care.

Join the movement today and be part of shaping the future of medicine. Together, we can unlock the full potential of peptides for better health worldwide.

Learn more:

Synthetic peptides now represent over 11% of FDA-approved drugs (2016–2024), revolutionizing personalized medicine with applications in autoimmunity, regeneration, and more.

11/12/2025

𝐁𝐮𝐫𝐞𝐚𝐮𝐜𝐫𝐚𝐭𝐢𝐜 𝐃𝐚𝐫𝐰𝐢𝐧𝐢𝐬𝐦: 𝐇𝐨𝐰 𝐈𝐧𝐜𝐞𝐧𝐭𝐢𝐯𝐞𝐬 𝐒𝐡𝐚𝐩𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞

Modern research doesn’t just study evolution — it’s subject to it. Incentives determine which scientists, ideas, and institutions survive.

Today, survival often favors those best adapted to the bureaucracy: those fluent in compliance, not necessarily in discovery. A principal investigator spends nearly half their time writing and resubmitting grants — sustaining the machinery that sustains itself.

Over time, this selection pressure produces a cognitive monoculture: safe, incremental projects optimized for funding success, not truth.

Realignment begins with metrics. Reward validated outcomes, replication, and real-world impact — not publication velocity. Incentives built for truth will again produce truth.

Modern research incentives prioritize outputs over insight, risking stagnation. Rebalancing metrics can restore curiosity, integrity, and true innovation in medicine.

10/30/2025

📣𝐃𝐨𝐧’𝐭 𝐌𝐢𝐬𝐬 𝐎𝐮𝐭! 𝐓𝐨𝐧𝐢𝐠𝐡𝐭’𝐬 𝐈𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬 𝐖𝐞𝐛𝐢𝐧𝐚𝐫 𝐚𝐝𝐝𝐫𝐞𝐬𝐬𝐞𝐬 𝐭𝐡𝐞 𝐩𝐫𝐢𝐦𝐚𝐜𝐲 𝐨𝐟 𝐪𝐮𝐚𝐥𝐢𝐭𝐲 𝐑𝐖𝐄 𝐟𝐨𝐫 𝐀𝐈 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐚𝐩𝐩𝐬.

Join us at 6:30 PM EST as Michael Tierney dives into how Circle Datasets are revolutionizing AI for clinical decision-making and medical research. Discover why these datasets are the foundation for groundbreaking advancements in healthcare technology.

If you haven't registered yet, there's still time — secure your spot now and gain exclusive insights into the future of AI in medicine.

𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐍𝐨𝐰: https://hubs.li/Q03QWsGX0

👉 Catch up first: Read our perspective on why Circle Datasets will be the foundation of AI in medicine: https://hubs.li/Q03QWrzS0

Looking forward to seeing you there!

10/30/2025

𝐓𝐡𝐞 𝐆𝐫𝐨𝐮𝐧𝐝 𝐓𝐫𝐮𝐭𝐡 𝐟𝐨𝐫 𝐀𝐈 𝐢𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐒𝐭𝐚𝐫𝐭𝐬 𝐇𝐞𝐫𝐞

AI in healthcare can only be as smart as the data it learns from. Most today is inconsistent, unverified, and context-free — making models statistically impressive but clinically unreliable.

RegenMed’s Circle Datasets change that. Every data element is structured, validated, and longitudinally tracked — creating the first high-signal, low-noise evidence base for both human and machine intelligence.

The result: safer models, smarter insights, and a new foundation for trustworthy AI in medicine: https://hubs.li/Q03QVTSl0

Unlock the future of healthcare with high-quality, interoperable real-world evidence that ensures reliable, actionable medical knowledge.

10/28/2025

Discover how Dr. Grant Pagdin and the Canadian Peptide Research Society are transforming therapy and regenerative medicine in Canada and North America. Join a community dedicated to innovation, safety, and cutting-edge research. Read more to explore their mission and upcoming events:

Join CPRS to advance safe, effective peptide therapies in regenerative medicine. Led by Dr. Grant Pagdin, connect with experts and explore cutting-edge research.

10/24/2025

Circle Datasets will be the foundation of AI used for clinical decision-making and medical research. Michael Tierney discusses why.

𝐌𝐚𝐫𝐤 𝐲𝐨𝐮𝐫 𝐜𝐚𝐥𝐞𝐧𝐝𝐚𝐫:

𝐃𝐚𝐭𝐞: Thursday October 30, 2025
𝐓𝐢𝐦𝐞: 6:30 PM EST

Register Now: https://hubs.li/Q03Q0l7j0

*𝘊𝘢𝘮𝘱𝘢𝘪𝘨𝘯 𝘦𝘯𝘥𝘴 𝘋𝘦𝘤𝘦𝘮𝘣𝘦𝘳 31, 2025.

10/23/2025

Which best describes your experience with peptides in clinical practice?

1. Regularly use peptides
2. Some experience, want more
3. New to peptides, curious
4. Haven’t used peptides yet

Please write your answer in the comments.

Interested in expanding your peptide knowledge? Join the Canadian Peptide Research Society for expert insights and latest research updates: https://www.rgnmed.com/cprs

10/22/2025

You’ve built through Circles. Now, it’s time to share it.

The Circles Physician Promotion Program gives you professional-grade content — webinars, articles, social media campaigns, and conference materials — all at no cost, fully compliant with medical and legal standards.

Turn your data into influence. Reach out to learn how: https://hubs.li/Q03P3Bf70

10/21/2025

Dr. Grant Pagdin, MD, board member of the Canadian Peptide Research Society, is advancing through the innovative use of combined with the inCytes platform to capture patient outcomes data. His initiative aims to provide transparent, data-driven insights on treatment effectiveness, improve patient care, and foster collaboration among practitioners dedicated to peptide-based therapies.

Dr. Pagdin invites fellow regenerative medicine and peptide specialists to join him in this important effort to collect and share real-world clinical data, enhancing the long-term safety and efficacy of these groundbreaking treatments.

Gain deeper insights from Dr. Pagdin at the 𝐂𝐀𝐎𝐌 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞, 𝐎𝐜𝐭𝐨𝐛𝐞𝐫 𝟐𝟑-𝟐𝟓. Connect with leaders in peptide research and regenerative medicine to collaborate, innovate, and elevate .

Experts eager to collaborate on this cutting-edge project are invited to get in touch. More details here: https://hubs.li/Q03PstPw0